<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
	<title>Proactiveinvestors United Kingdom Rexahn Pharmaceuticals items</title>
	<link>http://www.proactiveinvestors.co.uk</link>
	<description>Proactiveinvestors United Kingdom Rexahn Pharmaceuticals items RSS feed
            </description>
	<language>en</language>
	<pubDate>Wed, 23 May 2012 23:54:53 +0100</pubDate>
	<docs>http://blogs.law.harvard.edu/tech/rss</docs>
	<generator>Genera CMS</generator>
	<managingEditor>action@proactiveinvestors.com (Proactiveinvestors)</managingEditor>
	<webMaster>action@proactiveinvestors.com (Proactiveinvestors)</webMaster>
	<atom:link href="http://www.proactiveinvestors.co.uk/LON:RNN/Rexahn-Pharmaceuticals/rss/media" rel="self" type="application/rss+xml" />
		<item>
			<title><![CDATA[Rick Soni, President and COO of Rexahn Pharmaceuticals, talks to Proactiveinvestors ]]></title>
			<link>http://www.proactiveinvestors.co.uk/companies/ceo_focus/424/rick-soni-president-and-coo-of-rexahn-pharmaceuticals-talks-to-proactiveinvestors-424.html</link>
			<description><![CDATA[Rick Soni, President and COO of Rexahn Pharmaceuticals, talks about a strong positive signal that Serdaxin can work as an anti-depressant, a planned Phase 2b trial for this application, a partnership with Teva Pharmaceuticals, Zoraxel as a possible treatment for erectile dysfunction, and Archexins Phase 2 trials for pancreatic cancer.]]></description>
			<pubDate>Mon, 26 Apr 2010 00:00:00 +0100</pubDate>
			<guid>http://www.proactiveinvestors.co.uk/companies/ceo_focus/424/rick-soni-president-and-coo-of-rexahn-pharmaceuticals-talks-to-proactiveinvestors-424.html</guid>
		</item>
</channel>
</rss>

